Subscribe: Market Wire - Pharmaceuticals and Biotech: Biotech
Added By: Feedage Forager Feedage Grade B rated
Language: English
announced  announces  cannabis  clinical  company  marketwired oct  marketwired october  marketwired  new  oct  october  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Biotech

Marketwired - Biotech

Marketwired - Biotech

Last Build Date: Fri, 21 Oct 2016 17:54:08 EDT

Copyright: Copyright: (C) Marketwired

eWellness Announces Its Commercial Launch of its PHZIO Telemedicine Platform

Fri, 21 Oct 2016 16:58:43 EDT

CULVER CITY, CA--(Marketwired - Oct 21, 2016) -  eWellness Healthcare Corporation, (OTCQB: EWLL) is the first physical therapy ("PT") telemedicine company to offer insurance reimbursable real-time distance monitored physical therapy treatments. The Company is pleased to announce that it successfully held its commercial launch of its PHZIO PT telemedicine intervention system as a Tier 1 sponsor of the American Physical Therapy Association ("APTA"), Private Practice Section (PPS) Annual Conference held in Las Vegas.

ImmuCell Corporation Announces Closing of $3.5 Million Private Placement of Common Stock

Fri, 21 Oct 2016 13:37:37 EDT

PORTLAND, ME--(Marketwired - October 21, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced the closing of a previously announced private placement of 659,880 shares of common stock to nineteen investors at a price of $5.25 per share (the "Offering").

Cannabis Science Announces Products Hitting Shelves in Legal Dispensaries in the State of California

Fri, 21 Oct 2016 11:09:29 EDT

IRVINE, CA--(Marketwired - Oct 21, 2016) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce Cannabis Science Products are now hitting shelves in legal dispensaries within the State of California.

SafetyChain Software to Showcase Food Safety & Quality Management Solutions at 2016 SQF International Conference in Orlando, Florida

Fri, 21 Oct 2016 10:10:00 EDT

Visit SafetyChain at SQF's annual conference to learn how companies throughout the food supply chain are more effectively managing SQF compliance with SafetyChain

Clinical Ink Reports Record Contract Signings in Q3 - $16M in Bookings

Fri, 21 Oct 2016 09:30:00 EDT

PHILADELPHIA, PA and CAMBRIDGE, MA--(Marketwired - October 21, 2016) - Clinical Ink, the pioneering provider of eSource and patient engagement technologies for clinical trials, today announced record quarterly contract bookings of $16M in the third quarter of 2016.

Leveraging Smartphone Sensors to Measure Novel Health Outcomes, New Webinar Hosted by Xtalks

Fri, 21 Oct 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - October 21, 2016) - During an informative session, Dr. Bill Byrom, PhD, Senior Director of Product Innovation at ICON, Christian Gossens, PhD, MBA, Global Head of Early Development Workflows at F. Hoffman-La Roche Ltd and Professor Guillermo Sapiro, PhD, Electrical and Computer Engineering at Duke University will provide insight on three broad areas:

Scott Watson promoted to global chief creative officer at Ogilvy CommonHealth Worldwide

Fri, 21 Oct 2016 07:00:00 EDT

PARSIPPANY, NJ--(Marketwired - Oct 21, 2016) - Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced Scott Watson has been elevated from EVP, chief creative officer of the NJ-based Ogilvy CommonHealth arm of Ogilvy CommonHealth Worldwide, to global chief creative officer of the entire network.

Amlan International Adds Staff to Accommodate Growth in China

Thu, 20 Oct 2016 16:15:00 EDT

SHENZHEN, CHINA--(Marketwired - Oct 20, 2016) -  Amlan International announces the addition of three new hires to its China subsidiary, Amlan Trading (Shenzhen) Company, Ltd., keeping pace with growth due to expanding market penetration. The new sales managers were hired to increase service in different regions of China.

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2016

Thu, 20 Oct 2016 16:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 20, 2016) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on commercializing treatments for rare diseases such as Cystinuria, Wilson's disease and Rett Syndrome, today announced its results for the fiscal year ended June 30, 2016. The Audited Financial Statements and Management's Discussion and Analysis for the year ended June 30, 2016, may be viewed on SEDAR at

AlliancePharma annonce la clôture du placement privé annoncé précédemment avec Partenaires Persistence Capital

Thu, 20 Oct 2016 15:01:26 EDT

THETFORD MINES, QUÉBEC--(Marketwired - 20 oct. 2016) - AlliancePharma inc. (TSX CROISSANCE:APA) (« AlliancePharma » ou la « Société ») est heureuse d'annoncer qu'elle a émis un total de 40 000 actions privilégiées de série A à Partenaires Persistance Capital dans le cadre du placement privé de 4 000 000 $ annoncé le 4 juillet 2016 (le « Placement Privé »).

AlliancePharma Announces Closing of Previously Announced Private Placement with Persistence Capital Partners

Thu, 20 Oct 2016 15:00:41 EDT

THETFORD MINES, QUEBEC--(Marketwired - Oct. 20, 2016) - AlliancePharma Inc. (TSX VENTURE:APA) ("AlliancePharma" or the "Corporation") is pleased to announce that it has issued an aggregate of 40 000 Series A Preferred Shares to Persistence Capital Partners in connection with the $4,000,000 private placement previously announced on July 4, 2016 (the "Private Placement").

GeoVax HIV Vaccine Clinical Data Presented At HIVR4P Conference

Thu, 20 Oct 2016 14:30:00 EDT

Vaccine Shown to Induce Durable Functional Antibodies Against HIV

PBMI's 2016 Report Shows a Slight Increase in Overall Satisfaction Scores with PBM Services

Thu, 20 Oct 2016 13:30:00 EDT

PLANO, TX--(Marketwired - Oct 20, 2016) - Overall satisfaction with PBMs continues to hold relatively steady with a slight increase from 7.7 in 2015 to 7.8 in 2016. This is just one of the results from PBMI's 2016 PBM Customer Satisfaction Report, released today. The report includes responses from 507 benefit leaders representing employers providing drug benefit coverage for an estimated 54.7 million covered lives.

Media Alert: How Food Processing Companies are Taking Control of Material Loss

Thu, 20 Oct 2016 13:05:00 EDT

October 28 Webinar hosted by SafetyChain for Food Processing companies who want to learn how to minimize impact of material loss throughout the production process and on the bottom line

JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D

Thu, 20 Oct 2016 13:00:00 EDT

TORONTO, ON--(Marketwired - October 20, 2016) - JDRF and the University of Toronto are pleased to announce a $400,000 (USD) research grant to support the development of a skin [transdermal] patch to prevent hypoglycemia - a common, potentially life-threatening, risk for people living with type 1 diabetes (T1D).

Philips Healthcare, Medtronic Projected to Increase their Market Share Despite Competition and Reduced Healthcare Budgets

Thu, 20 Oct 2016 12:20:24 EDT

The patient monitoring market in Europe is expected to increase over the next several years to reach over EUR1.8 billion by 2022.

3D Cell Culture Experts Assemble for Inaugural New Frontiers in 3D Conference

Thu, 20 Oct 2016 12:19:04 EDT

Event draws over 100 leading government, industry, and academic leaders to further translational applications of 3D tissue models

Popular Science Recognizes Probuphine as One of the 2016 "Best of What's New"

Thu, 20 Oct 2016 12:00:00 EDT

SOUTH SAN FRANCISCO, CA--(Marketwired - Oct 20, 2016) - Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeuraT long-term, continuous drug delivery platform, is very pleased that Probuphine® has been recognized as one of the "12 Most Important Innovations of the Year" in the Health category in Popular Science's annual "Best of What's New" issue. Probuphine, a subdermal implant developed using Titan's proprietary ProNeura technology, was approved by the U.S. Food and Drug Administration in May 2016, becoming the first commercially available long-term maintenance treatment of opioid dependence in clinically stable patients on 8 mg or less a day of oral buprenorphine.

Orgenesis CEO Vered Caplan to Present at T1D Exchange Annual Meeting

Thu, 20 Oct 2016 10:19:02 EDT

GERMANTOWN, MD--(Marketwired - Oct 20, 2016) - Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and contract development and manufacturing company, announced that Orgenesis CEO, Vered Caplan, will present at the T1D Exchange 4th Annual Meeting, which is being held at the Royal Sonesta Hotel in Boston, Massachusetts on October 21, 2016. Ms. Caplan will speak on the panel "Cellular and Biopharmaceutical Innovations."

iRemedy Healthcare Engages J. Streicher Capital as Investment Banker and Capital Markets Advisor

Thu, 20 Oct 2016 09:00:00 EDT

STUART, FL--(Marketwired - Oct 20, 2016) - iRemedy Healthcare, Inc., a SaaS business dedicated to enhancing practice profitability by providing the efficient distribution of products to and through healthcare organizations, today announced its engagement of J.Streicher Capital LLC as exclusive capital market advisor and placement agent for the Company.

ActivX Biosciences Publishes Two Key Articles Demonstrating Breadth of Applications for KiNativ(R) Technology in Drug Discovery

Thu, 20 Oct 2016 09:00:00 EDT

LA JOLLA, CA--(Marketwired - Oct 20, 2016) -  ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile, peer-reviewed journals by ActivX® researchers and their collaborators that highlight the broad utility of the industry-leading KiNativ® kinase profiling platform.

First-Ever Legal Cannabis Investment Study: 68% of Investors Are Now Open to Businesses that Touch Marijuana

Thu, 20 Oct 2016 09:00:00 EDT

WASHINGTON, DC--(Marketwired - October 20, 2016) - New Frontier Data, the authority in cannabis Big Data and analytics, in partnership with Arcview Market Research, the leading publisher of cannabis market research, and The Arcview Investor Network, the leading private forum for high net worth accredited investors, has released its 2016 Cannabis Investment Study. The study unveils insights from Arcview's members and shows that despite the differences in regulations affecting businesses that touch cannabis and ancillary businesses that do not touch cannabis, the majority of investors (68%) are now interested in opportunities on both sides of the market.

Vaxil Announces Strategic Collaboration With Hadassah

Thu, 20 Oct 2016 09:00:00 EDT

Appointment of Top Hadassah Physician Scientist Professor Dr. Michael Shapira to Vaxil Scientific Advisory Board; Appointment of New CEO and Board Member

Sipp Industries Secures Partnership with Distinguished Brewery for Enhanced Production Capacity and Provides Update on Hemp and CBD Beer Initiatives

Thu, 20 Oct 2016 08:30:00 EDT

COSTA MESA, CA--(Marketwired - Oct 20, 2016) - Sipp Industries, Inc. (OTC PINK: SIPC), a multifaceted corporation specializing in technology, manufacturing, and distribution of commercial and consumer products is pleased to announce the Company has entered into a contractual agreement with a notable Colorado brewery. In anticipation of rising demand upon licensing, the Company has mobilized to strengthen the Company's production capacity.

American Cannabis Company, Inc. Announces New Contract for Canadian Based Firm Seeking to Become Licensed Producer

Thu, 20 Oct 2016 08:30:00 EDT

DENVER, CO--(Marketwired - Oct 20, 2016) - American Cannabis Company, Inc.T (OTCQB: AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced that it has secured a new design and consulting contract with a Canadian firm for the purpose of creating a cannabis Licensed Producer facility within the Atlantic provinces.

ViroCyt(R) Develops Rapid Detection System for Enterovirus 71

Thu, 20 Oct 2016 08:30:00 EDT

BROOMFIELD, CO--(Marketwired - October 20, 2016) - ViroCyt®, the innovator in rapid virus quantification, and recently acquired by Sartorius, a leading international pharmaceutical and laboratory equipment provider, announced today the addition of another member of its ViroTag® portfolio of antibody-based detection reagents: ViroTag EV71.

Big Pharma's Getting Back Together with Medical Education

Thu, 20 Oct 2016 08:17:00 EDT

Nine out of ten global pharma teams provide funding for accredited CME

Pieris Announces Presentations at Upcoming R&D Conferences

Thu, 20 Oct 2016 08:00:00 EDT

BOSTON, MA--(Marketwired - October 20, 2016) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer and other diseases, announced today presentations at two upcoming R&D conferences focused on immuno-oncology.

Moleculin Announces Reminder for Conference Call to Discuss Positive Developments Regarding Annamycin

Thu, 20 Oct 2016 08:00:00 EDT

Call Scheduled for Today to Include General Corporate Update

Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at Orphan Drugs & Rare Disease Conference, London UK

Thu, 20 Oct 2016 07:43:00 EDT

NEW YORK, NY and CLEVELAND, OH--(Marketwired - October 20, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO):

Applying Sound Research Practices in Development of Medical Devices, a New Webinar Presented by Premier Research

Thu, 20 Oct 2016 07:15:00 EDT

TORONTO, ON--(Marketwired - October 20, 2016) - Medical device and diagnostic companies face greater demand to provide clinical evidence of product efficacy than ever before. Scrutiny not only from regulators, but from healthcare systems, physicians, and even patients, has prompted more device companies to perform clinical trials to meet regulatory requirements, differentiate their products, and improve the likelihood of commercial success. While these are similar to well-established pharma clinical studies, there are significant differences.

Using Synthetic Carbohydrates as Biological Targeting and Delivery Agents, New Webinar Hosted by Xtalks

Thu, 20 Oct 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - October 20, 2016) - In an informative session, industry expert Dr. Stewart Campbell, the Head of Business Development and Product Management, Carbohydrates from CordenPharma Switzerland/Woburn will discuss two areas with the goal of demonstrating that carbohydrates are indeed accessible and can be practical alternatives or adjuncts to more traditional targeting approaches. These two areas are:

SOTIO and NBE Therapeutics sign license agreement

Thu, 20 Oct 2016 05:57:29 EDT

PRAGUE, CZECH REPUBLIC--(Marketwired - Oct 20, 2016) -

Zecotek Signs Cooperation Agreement for $5 Million Equity Stake in Zecotek Imaging Systems

Thu, 20 Oct 2016 03:30:00 EDT

SINGAPORE, SINGAPORE--(Marketwired - Oct. 20, 2016) - Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I)(OTC PINK:ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that it has signed a cooperation agreement with the Shanghai Creation Investment Management Company (SCI) to initiate a US$5 million financing into its wholly owned subsidiary, Zecotek Imaging Systems Pte Ltd. The agreement calls for a maximum equity position of 10% of Zecotek Imaging stake, with the final valuation contingent upon the execution of the previously announced MOU, with a Chinese PET manufacturer. The investment in Zecotek Imaging Systems will be used to build out the necessary organizational and operational infrastructure, and add China based management to deliver its patented imaging technologies to the Chinese medical PET industry.

Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux

Wed, 19 Oct 2016 20:15:24 EDT

NORTHRIDGE, CA and PERTH, AUSTRALIA and LONDON, UNITED KINGDOM--(Marketwired - Oct 19, 2016) - Avita Medical Ltd, (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specialising in new treatments for wounds and skin defects, has identified distribution partners for its medical devices in South Africa and the three Benelux nations, the Company said today.

Helix BioPharma Corp. Announces CAR-T Poster Presentation at the AACR Conference on Tumor Immunology and Immunotherapy

Wed, 19 Oct 2016 18:42:21 EDT

CAR-T Cells Harboring Camelid Single Domain Antibody as Targeting Agent to CEACAM6 Antigen in Pancreatic Cancer

MEDIA ADVISORY: Canada's regenerative medicine community is in Whistler for fifth annual Till & McCulloch Meetings

Wed, 19 Oct 2016 18:02:24 EDT

TORONTO, ON--(Marketwired - October 19, 2016) - Canadian and international stem cell scientists and engineers will be in Whistler, British Columbia, October 24-26 to attend the Till & McCulloch Meetings (TMM), Canada's premier stem cell research event. Over 400 delegates are expected to attend. The agenda, featuring speakers and special events, is available here. Media are invited to register, free of charge, to monitor the scientific sessions.

Kerecis Introduces its Fish-Skin Wound Treatment to the Asian Market at Major Medical Congress

Wed, 19 Oct 2016 17:20:51 EDT

Distributor Recura to display the Omega3-rich Kerecis product in the Villa 4 exhibit area

Nerium Biotechnology Announces the Appointment of Kerry Mitchell to its Board of Directors

Wed, 19 Oct 2016 16:30:00 EDT

SAN ANTONIO, TEXAS--(Marketwired - Oct. 19, 2016) - Nerium Biotechnology, Inc. ("Nerium") announced today the appointment of Kerry Mitchell to its board of directors. Ms. Mitchell has extensive experience as a media executive, with a strong record of building and transforming multi-platform media brands that include some of the most iconic names in Canadian publishing.

Pegasystems to Announce Financial Results for the Third Quarter of 2016 via Conference Call and Webcast

Wed, 19 Oct 2016 16:05:00 EDT

CAMBRIDGE, MA--(Marketwired - October 19, 2016) - Pegasystems Inc. (NASDAQ: PEGA), the software company empowering customer engagement for the world's leading enterprises, today announced it will report financial results for the third quarter of 2016 on Wednesday, November 2, after market close.

Sarah Herron and Stars from the Bachelor Series Help Raise Fetal Health Awareness at Great Candy Run

Wed, 19 Oct 2016 15:08:36 EDT

More than 6,000 Runners and Walkers Expected at Wash Park on November 6th

Cannabis Science Negotiates an Additional 200 Acres in California and 100 Acres in Nevada for Indoor and Outdoor Grow and Production Operations, Keys for Large-Scale Nationwide Growth Strategy

Wed, 19 Oct 2016 11:03:01 EDT

IRVINE, CA--(Marketwired - Oct 19, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the process of negotiating for another couple of major new drug development property deals, this time for two properties, a 200-acre California property and a 100-acre property in Nevada.

DTRA and Navy Looking to Sharks for Warfighter Protection

Wed, 19 Oct 2016 10:47:58 EDT

FORT BELVOIR, VA--(Marketwired - October 19, 2016) - In new research funded by the Defense Threat Reduction Agency's Joint Science and Technology Office (JSTO) and performed by U.S. Naval Research Laboratory (NRL) scientists, shark antibodies are proving to offer new alternatives to chemical and biological threat detection and treatment tools. In an era of Department of Defense belt-tightening, the goal is to find more innovative, cost-effective approaches to protecting our warfighters.

OncBioMune Receives Notice of Patent Allowance for Novel Cancer Vaccine ProscaVax(TM) in Mexico

Wed, 19 Oct 2016 10:05:19 EDT

BATON ROUGE, LA--(Marketwired - October 19, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, today announces that the Company has received a Notice of Allowance from the Mexican Institute of Industrial Property for OncBioMune's patent application number MX/a/2013/008188. The patent covers ProscaVaxT, OncBioMune's novel cancer vaccine in clinical development, as a composition and method for treating cancer.

Medical Marijuana, Inc. CEO to Speak on Cannabis Investment Opportunities at Money Show Dallas

Wed, 19 Oct 2016 09:00:00 EDT

First-Ever Publicly Traded Cannabis Company in U.S. to Sponsor Money Show Dallas' Welcome Reception; RSHO(TM) Parent Advocate Penny Howard to Speak About CBD Hemp Oil

Oasis Diagnostics(R) and NYU College of Dentistry Announce the North American Saliva Symposium

Wed, 19 Oct 2016 08:30:00 EDT

VANCOUVER, WA--(Marketwired - October 19, 2016) - Oasis Diagnostics®, an innovative biotechnology company focused on developing cutting edge tools for saliva sample acquisition and testing, announced that it will be co-hosting the annual North American Saliva Symposium (NASS) with the prestigious New York University College of Dentistry, in New York City, from December 9th through the 11th, 2016

Microbix Announces Preliminary Sales for 2016

Wed, 19 Oct 2016 08:30:00 EDT

Record Sales for Fourth Quarter and Full Year

Tetra Bio-Pharma Announces Awarding of NSERC Engage Grant Partnership to Grow Pros MMP and McGill University

Wed, 19 Oct 2016 08:25:12 EDT

OTTAWA, ONTARIO--(Marketwired - Oct. 19, 2016) - Grow Pros MMP Inc. (MMP), a subsidiary of Tetra Bio-Pharma Inc. ("TetraBio" or the "Company" or "TBP") (CSE:TBP) is pleased to announce that the National Sciences and Engineering Research Council of Canada (NSERC) has awarded an NSERC Engage Grant partnership to MMP and Dr. Stan Kubow of McGill University.

Big Pharma Expanding Patient Centricity through Top-Down Mandates

Wed, 19 Oct 2016 08:17:00 EDT

Study finds that two-thirds of Top 50 drug companies have a top-down patient-centric mandate in place

Kareo Launches Solution to Reduce Prescription Drug Costs for Patients

Wed, 19 Oct 2016 08:15:00 EDT

Pricing transparency and instant savings now available to independent physicians and their patients

Advanced Proteome Therapeutics Corporation Obtains Option to License Antibody Candidates and Collaborates With CCAB to Jointly Fund Research

Wed, 19 Oct 2016 08:00:00 EDT

VANCOUVER, BC--(Marketwired - October 19, 2016) - Advanced Proteome Therapeutics Corporation (APC) (TSX VENTURE: APC) (FRANKFURT: 0E8), a biopharmaceutical company dedicated to creating, developing, and commercializing innovative therapies, today announced that it has entered into an exclusive option agreement with the Toronto Recombinant Antibody Centre (TRAC) at the University of Toronto (UT). APC acquired an option to license validated antibody candidates suited for development of antibody-drug conjugates (ADCs) as potential treatments for cancer.

Kane Biotech Launches New Branding for StrixNB Oral Health Products for Dogs and Cats

Wed, 19 Oct 2016 08:00:00 EDT

WINNIPEG, MANITOBA--(Marketwired - Oct. 19, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce the launch of new packaging and branding for StrixNBT.

Adgero Biopharmaceuticals Expands Executive Management Team with Appointment of Laura Edgerly-Pflug as Vice President of Manufacturing Operations and Quality Control

Wed, 19 Oct 2016 07:30:00 EDT

Strengthening team with extensive experience in product and process development and scale-up from bench to commercial process

Big Data Poised to Lower Health Care Costs

Wed, 19 Oct 2016 07:30:00 EDT

Data-driven advances like artificial intelligence and personalized therapy can bring about cost cuts that reforms like Obamacare have failed to deliver, while improving quality, says Lux Research

Nlyte Software Positioned as a Leader in Gartner's DCIM Magic Quadrant

Wed, 19 Oct 2016 07:10:00 EDT

Third Consecutive Year Company Named as Leader; This Year Positioned Furthest for Vision and Highest for Execution

Xtalks Webinar to Discuss Patient Recruitment Strategies in Prodromal Alzheimer's Disease Clinical Trials

Wed, 19 Oct 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - October 19, 2016) - The webinar taking place on Tuesday, November 1 at 11:00 am. EDT will focus on strategic approaches to identify patients with Prodromal AD and connect them with a study site.

3D Signatures Included in Major Clinical Trial for Prostate Cancer

Wed, 19 Oct 2016 07:00:00 EDT

WINNIPEG, MB--(Marketwired - October 19, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD) (the "Company" or "3DS") is pleased to announce its participation in a major clinical trial for prostate cancer diagnosis and management known as PRECISE. This trial marks the Company's first step toward validation and approval of clinical risk assessment tests for prostate cancer.

Nohla Therapeutics Signs Exclusive Supply Agreement With LifeSouth Community Blood Centers

Wed, 19 Oct 2016 05:30:00 EDT

SEATTLE, WA--(Marketwired - Oct 19, 2016) - Nohla Therapeutics Inc. (Nohla), a leading developer of universal donor cellular therapies for the treatment of patients with life threatening hematological disorders, announced today the signing of an exclusive supply agreement with LifeSouth Community Blood Centers in Gainesville, Florida. The agreement is specific to LifeSouth's cord blood banking program and will provide Nohla with fully qualified clinical grade cord blood units that will become the starting material for the Company's expanded hematopoietic stem and progenitor cell products.

Prolifiq Software Expands Executive Team with New Chief Commercial Officer

Wed, 19 Oct 2016 03:00:00 EDT

Salesforce Veteran Will Drive Customer Acquisition for Innovative Life Sciences Commercial Content and Sales Enablement Company

Beleave Announces Adoption of Advance Notice By-Law

Tue, 18 Oct 2016 23:10:05 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 18, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE:BE) its board of directors (the "Board") has amended the Company's by-laws to include an advance notice requirement in connection with shareholders intending to nominate directors in certain circumstances (the "By-Law Amendment").

Kerecis Omega3-rich Fish-Skin Treatment for Wound Treatment to be Introduced to the Asian Market at a Major Medical Congress in Singapore

Tue, 18 Oct 2016 21:00:00 EDT

Distributor Recura to display the Kerecis product in the Villa 4 exhibit area

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell(R) in Life-Threatening Injuries

Tue, 18 Oct 2016 19:13:50 EDT

NORTHRIDGE, CA and PERTH, AUSTRALIA and LONDON, UNITED KINGDOM--(Marketwired - Oct 18, 2016) -

Mincom Capital Inc. Announces Intent to Acquire Braille Holdings Inc. as an Entry Point to the Lucrative Energy Storage Space With Next Generation Graphene Based Lithium Battery Technologies

Tue, 18 Oct 2016 17:36:03 EDT

OTTAWA, ONTARIO--(Marketwired - Oct. 18, 2016) - Mincom Capital Inc. ("Mincom") (TSX VENTURE:MOI) is pleased to announce it has entered into a non-binding letter of intent with Grafoid Inc. ("Grafoid") to acquire Grafoid's 75% interest in Braille Holdings Inc. ("Braille"), of Sarasota, Florida which owns Braille Battery.

Breathtec BioMedical Announces Private Placement

Tue, 18 Oct 2016 17:08:00 EDT

VANCOUVER, BC--(Marketwired - Oct 18, 2016) - Breathtec BioMedical, Inc. (CSE: BTH) (CNSX: BTH) (the "Company" or "Breathtec"), a medical diagnostics company focused on developing, in-licensing and commercializing proprietary, innovative and best-in-class breath analysis devices for the early detection of life threatening diseases, is pleased to announce that it intends to complete a non-brokered private placement offering of up to 13,333,333 units (the "Units") at a price of $0.075 per Unit for gross proceeds of up to $1,000,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (a "Share") and one transferable common share purchase warrant (a "Warrant"), with each Warrant exercisable into one additional Share at a price of $0.15 for a period of three years from the date of closing.

Lattice Biologics Closes Second Tranche of Private Placement Announced on September 13, 2016

Tue, 18 Oct 2016 16:49:11 EDT

Investors contribute US$200K as the Company sees widespread interest in its newly launched AmnioVisc(TM) product for osteoarthritis

Alcon, Abbott Medical Optics Lead Competitive Europe Interventional Ophthalmic Devices Market

Tue, 18 Oct 2016 13:20:40 EDT

The European market for diagnostic and interventional ophthalmic devices is expected to grow and exceed EUR1.9 billion by 2023

SuperSonic Imagine reports sales growth of +10% in Q3 2016

Tue, 18 Oct 2016 12:15:00 EDT

Solid growth in the United States; Further significant growth in Service sales

NobleStitch(TM) EL Featured at Italy's GISE Structural Heart Congress in Genova

Tue, 18 Oct 2016 11:28:37 EDT

Prof Giulio Speciale and Prof Achille Gaspardone Present the First Ever Italian Live Case of the NobleStitch(TM) EL Performed at the 2016 GISE Structural Heart Congress in Genova, Italy

eTMF Market Expected to Grow Considerably Over the Next Three Years

Tue, 18 Oct 2016 10:30:00 EDT

Informing the pharmaceutical drug development, manufacturing and commercialization industry

MEDIA ALERT: Industry Leaders to Discuss How Technology Enables Better Patient Outcomes During Pega Healthcare Summit

Tue, 18 Oct 2016 10:00:00 EDT

CAMBRIDGE, MA--(Marketwired - October 18, 2016) - Pegasystems (NASDAQ: PEGA)

Kirk McPoyle Joins Clinical Ink as Chief Commercial Officer

Tue, 18 Oct 2016 09:41:45 EDT

WINSTON-SALEM, NC and PHILADELPHIA, PA--(Marketwired - October 18, 2016) - Clinical Ink®, the leading provider of eSource and mobile patient engagement technologies for clinical trials, announces the addition of Kirk McPoyle to its management team. He has joined Clinical Ink as the Chief Commercial Officer.

Advantis Corp. CEO Highlights Newest Company Developments

Tue, 18 Oct 2016 09:26:00 EDT

NEWPORT BEACH, CA--(Marketwired - Oct 18, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Chris Swartz, was recently interviewed by SmallCapVoice and is taking the time to further update shareholders on the current state of business.

Synthego CRISPRevolution Synthetic Guide RNA Powers CRISPR Genome Research Worldwide

Tue, 18 Oct 2016 09:00:00 EDT

World Class Synthetic Guide RNA Provides Faster and More Efficient Gene Editing for Scientists Around the World

SECFilings Releases Report on Why Bioelectronics are the Future of Medicine

Tue, 18 Oct 2016 08:57:05 EDT

REDONDO BEACH, CA--(Marketwired - Oct 18, 2016) -, a leading financial news and information portal offering free real time public filing alerts, recently published a report on the emerging bioelectronic medicine industry. In the report, the differences between pulsed electromagnetic fields (PEMF) and surgical implants are discussed, along with companies that have become innovators in both sides of the industry. Companies discussed in the report include Endonovo Therapeutics Inc. (OTCQB: ENDV), GlaxoSmithKline plc, and Alphabet Inc.'s Verily Life Science LLC.

Wincanton Adopts Paragon Software Systems' fleXipod Electronic Proof of Delivery System

Tue, 18 Oct 2016 08:47:00 EDT

Streamlines Multi-Client Home Delivery Operations

Upcoming Webinar to Examine Pharmacogenetics in Pain Management and the Use of Pharmacogenomics Methodologies in the Pharmacovigilance Evaluation of Medicinal Products

Tue, 18 Oct 2016 08:17:27 EDT

TORONTO, ON--(Marketwired - October 18, 2016) - In this presentation Dr. Lynn Webster, Vice President of Scientific Affairs (Early Development Services), and Michael Marschler, Director of Safety and Risk Management, both from PRA Health Sciences, will discuss how pharmacogenetics can be integrated in clinical trials. The speakers will also outline post-marketing settings to achieve a personalized therapy and how considering missing information (potential risk(s)) of genomic variations can help to identify risk minimization measures to greatly reduce the risk of side effects and significantly increase the therapeutic benefit to the patients.

Drug Companies' Launch Sequencing Strategy Influences Approval Team Structure

Tue, 18 Oct 2016 08:17:00 EDT

75% of Pharma Companies have an Ad Hoc Committee Responsible for Launch Sequencing

Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement, New Webinar Hosted by Xtalks

Tue, 18 Oct 2016 08:15:45 EDT

TORONTO, ON--(Marketwired - October 18, 2016) - In this webinar, Lewis Millen, Operational Intelligence Leader from Roche Products Limited and Matt Kibby, President of BBK Worldwide will discuss how mHealth can improve patient recruitment, retention and engagement to create a better overall patient experience. They will outline how mHealth helps remove key communication barriers and improve multi-stakeholder collaboration and streamline recruitment and engagement tactics -- all while reducing study inefficiencies and overall costs. The live session will take place Friday, October 28, 2016 at 12pm EDT.

Functional Brain Imaging Using MRI: An Emerging Tool for Drug Development and Clinical Trials, Upcoming Webinar Hosted by Xtalks

Tue, 18 Oct 2016 08:13:52 EDT

TORONTO, ON--(Marketwired - October 18, 2016) - During a live presentation on Friday, October 28, 2016, Dr. Maria Laura Blefari, Biomedical Engineer from WorldCare Clinical and Dr. Mykol Larvie, Physician, Department of Radiology, Director of Molecular Neuroimaging, Massachusetts General Hospital will extend their expertise and provide:

ImmuCell to Raise $3.5 Million in Private Placement

Tue, 18 Oct 2016 08:07:35 EDT

PORTLAND, ME--(Marketwired - October 18, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced it has entered into definitive agreements with institutional and accredited investors for the private placement of approximately $3.5 million of ImmuCell's common stock.

Theravance Biopharma to Present New Data from Multiple Studies of VIBATIV(R) (telavancin), Including Ongoing TOUR(TM) Observational Patient Registry, at IDWeek 2016

Tue, 18 Oct 2016 08:05:00 EDT

First Presentation of TOUR Data Highlights Real World Experience with VIBATIV in Range of Difficult-to-Treat Infections; Additional VIBATIV Presentations Report Results from Retrospective Analysis in Osteomyelitis Patients and Multiple Studies Evaluating in vitro Potency in Challenging Pathogens Compared to Other Commercialized Antibiotics

ImmuCell Announces Preliminary Third Quarter 2016 Financial Results

Tue, 18 Oct 2016 08:00:00 EDT

PORTLAND, ME--(Marketwired - October 18, 2016) - ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced preliminary financial results for the third quarter of 2016. The following amounts discussed in this press release are unaudited and preliminary and are subject to completion of the customary closing and review procedures by the Company's management and independent auditors following the quarter end, among other factors. The Company expects to report its full financial results for the quarter on November 10, 2016 at 4:05 PM ET, followed by a conference call at 4:30 PM ET.

THC BioMed Receives License Amendment

Tue, 18 Oct 2016 08:00:00 EDT

VANCOUVER, BC--(Marketwired - October 18, 2016) - THC BioMed Ltd. (CSE: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) ("THC" or the "Company") is pleased to report that it has had its license amended by Health Canada and will begin to initiate its business plan by inter-trading between licensed producers to strengthen its products and service.

Aphria and MassRoots Partner in One of First International Collaborations between Cannabis Companies

Tue, 18 Oct 2016 08:00:00 EDT

LEAMINGTON, ONTARIO--(Marketwired - Oct. 18, 2016) - Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) (OTCQB:APHQF) one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc., one of the largest technology platforms for the cannabis industry, are pleased to announce they have entered into one of the first international partnerships between cannabis companies. Under the terms of the agreement, MassRoots will help build awareness of the Aphria brand amongst its Canadian userbase. Aphria will compensate MassRoots a cash fee (in U.S. dollars) it refers.

Biomerica Announces First Quarter Fiscal 2017 Financial Results, Sales Increase Over Prior Year

Tue, 18 Oct 2016 07:57:00 EDT

IRVINE, CA--(Marketwired - October 18, 2016) - Biomerica, Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic products, today reported net sales of $1,410,110 for the three months ending August 31, 2016, compared to $1,286,993 for the same period in the previous year, an increase of nearly 10%.

Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-102 Gene Therapy in Sanfilippo Syndrome Type A

Tue, 18 Oct 2016 07:45:00 EDT

NEW YORK, NY, and CLEVELAND, OH--(Marketwired - October 18, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical- stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation for Abeona's lead gene therapy program ABO-102 for the treatment of patients with Sanfilippo syndrome type A (MPS IIIA), a rare autosomal recessive disease that causes neurocognitive decline, speech loss, loss of mobility, and premature death in children.

Endonovo Therapeutics Announces Registration Statement on Form S-1 has been Declared Effective

Tue, 18 Oct 2016 07:05:00 EDT

Financing will Allow Endonovo to Conduct Pre-Clinical Studies on Liver Inflammation and Regeneration Using the Company's Non-Invasive Electroceutical Platform

Corbus Pharmaceuticals Receives Orphan Designation for Resunab for the Treatment of Cystic Fibrosis in the European Union

Tue, 18 Oct 2016 07:00:00 EDT

Company on track to complete Phase 2 study in cystic fibrosis in 2016; Phase 2 topline results expected Q1 2017

KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion(R) Abuse-Deterrent Technology

Tue, 18 Oct 2016 06:30:00 EDT

Agreement focused on KemPharm's current and in-development IR Opioid Pipeline

Argentina's Top Poultry Producers Visit Chicago for Insight on AGP Alternatives

Mon, 17 Oct 2016 17:00:52 EDT

CHICAGO, IL--(Marketwired - Oct 17, 2016) - Argentina's largest poultry producers and integrators recently traveled to Chicago to gain insight on current production practices and emerging solutions available from the U.S. market. The group, accompanied by representatives from Elanco, the biggest distributor of antibiotics in Argentina, attended a special presentation and discussion about Varium, a new non-antibiotic growth promoter from Amlan International. They also toured the Chicago Board of Trade and Chicago Mercantile Exchange, and gained insight on grain markets from Celina Mesquida, agricultural analyst at RJ O'Brien.

ITUS Receives Notice of NASDAQ Continued Listing Compliance

Mon, 17 Oct 2016 13:01:37 EDT

LOS ANGELES, CA--(Marketwired - October 17, 2016) - ITUS Corporation ("ITUS") (NASDAQ: ITUS), today announced that it has received formal notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC that the company has evidenced compliance with all requirements for continued listing on The Nasdaq Capital Market. On August 24, 2016, the company was notified by NASDAQ that it no longer met the minimum continued listing requirements, and the August 24 matter is now closed.

Medifirst Solutions Announces Update Regarding Sales and Operations

Mon, 17 Oct 2016 13:00:53 EDT

FREEHOLD, NJ--(Marketwired - Oct 17, 2016) -  MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) (the "Company" or "Medifirst") would like to update shareholders regarding recent company developments regarding its FDA cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.

PRISM Logistics to Sponsor CSCMP San Francisco Lunch Collaboration with BioSupply Management Alliance (BSMA) THURSDAY Oct. 20th

Mon, 17 Oct 2016 11:56:59 EDT

A.T. Kearney Will Deliver Keynote State of Logistics Report and Moderate Discussion with Biolog Europe, Bio-Rad Laboratories on 'Preparing Biotech Supply Chain for 2025'

Pegasystems and MCG Health Partner to Integrate Industry-Leading Chronic Care Standards in Pega Care Management Application

Mon, 17 Oct 2016 10:00:00 EDT

Partnership Will Enable Care Management Teams to Drive Better Health Outcomes for Patients

3D Signatures Letter to Shareholders

Mon, 17 Oct 2016 09:30:00 EDT

WINNIPEG, MB--(Marketwired - October 17, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD) (the "Company" or "3DS"), a personalized medicine company developing precision clinical tests using a proprietary software platform based on three-dimensional analysis of chromosomal signatures, is pleased to provide a letter to shareholders providing guidance and insight into the Company's milestones over the coming year. Jason Flowerday, the Company's CEO, is excited to report on the company's early progress and to provide a roadmap to commercialization.

CBIS Breaking News: Polling by UC Berkeley Recently Shows Nearly 2:1 Voting Support Passing Proposition 64 in California; CNET Reports: Virgin's Sir Richard Branson to Cannabis Advocates: Fight to Legalize it

Mon, 17 Oct 2016 09:12:09 EDT

More Historic Days Ahead, November the 8th: Voters in Five States -- California, Arizona, Massachusetts, Maine and Nevada -- Will Decide to Fully Legalize and Regulate Marijuana

Pharmaceutical & Healthcare Leaders Collaborate to Improve the Patient Journey

Mon, 17 Oct 2016 09:01:00 EDT

End-to-End Self-Injection Platform to Improve Adherence Showcased at 2016 PDA Universe of Pre-filled Syringes and Injection Devices

Phase 3 Enrollment Initiated in Japan for Versartis' Long-Acting Growth Hormone Based on Amunix's XTEN(R) Technology

Mon, 17 Oct 2016 09:00:00 EDT

MOUNTAIN VIEW, CA--(Marketwired - October 17, 2016) - Amunix is pleased to announce that Versartis Inc. (NASDAQ: VSAR) has been granted approval in Japan by the PMDA to initiate enrollment for its Phase 3 study of somavaratan (XTENylated recombinant growth hormone) in pediatric patients with growth hormone deficiency (GHD).

Aequus Advances Clinical Development of Transdermal Aripiprazole Patch

Mon, 17 Oct 2016 09:00:00 EDT

VANCOUVER, BC--(Marketwired - October 17, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that is has filed a Clinical Trial Application (CTA) with Health Canada for its once-weekly transdermal aripiprazole patch. Aequus has developed this product to provide patients with sustained and controlled delivery of aripiprazole in a convenient, weekly dosage form. Upon approval of the CTA, the Company plans to initiate a repeat dose, 28-day safety and bioavailability study of aripiprazole transdermal patches in eight healthy volunteers in late 2016.

Breathtec BioMedical Provides Corporate Overview

Mon, 17 Oct 2016 08:30:00 EDT

Company Offers Update of Events and Outlook for Near Term Opportunity